Related Experiment Video

Updated: Aug 27, 2025

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
11:28

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

11.1K

[Human retrovirus XMRV: The end of an exciting story?]

Sonia Assil1, Pierre-Adrien Bolze1, Myriam Boukhali1

  • 1École normale supérieure de Lyon, département de biologie, master biosciences, 46, allée d'Italie, 69007 Lyon, France.

Virologie (Montrouge, France)
|September 24, 2022
PubMed

Insights

Xenotropic MLV-related virus (XMRV) was investigated as a cause of human prostate cancer. Recent evidence refutes XMRV

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Context:

  • Viruses are a significant cause of human cancers, with infections linked to nearly 20% of cancer cases.
  • The discovery of xenotropic MLV-related virus (XMRV) in prostate cancer biopsies in 2006 spurred research into its potential oncogenic role.
  • Ongoing discovery of novel infectious agents suggests a potential increase in virus-associated cancers.

Purpose:

  • To review the discovery and initial investigation of xenotropic MLV-related virus (XMRV) in relation to prostate cancer.
  • To critically analyze recent scientific data that challenges the hypothesis of XMRV infection in humans.
  • To provide a synthesized interpretation of the existing XMRV literature.

Summary:

  • Xenotropic MLV-related virus (XMRV) was identified in prostate cancer patients, leading to hypotheses of its causal role.
  • Subsequent research and data analysis have increasingly refuted the presence and role of XMRV in human prostate cancer.
  • The scientific community's initial enthusiasm has waned as evidence against XMRV's human relevance has accumulated.

Impact:

  • This review consolidates evidence against XMRV as a human pathogen, particularly in prostate cancer.
  • It aims to guide future research directions by clarifying the current scientific consensus on XMRV.
  • Understanding the role of viruses in cancer is crucial for public health and developing targeted therapies.
Keywords:
XMRVcontaminationepidemiologyoncogenic retrovirusprostate cancer

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions10:10

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions

Published on: May 28, 2017

8.5K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
LTR Retrotransposons03:08

LTR Retrotransposons

LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
17.8K